Parkinson’s treatment tested at UW showing promise in first clinical trial

by admin | Oct 24, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Chris Barncard – University of Wisconsin News – Parkinson’s patients are receiving a new investigational treatment after a successful study at the University of Wisconsin–Madison helped demonstrate the cell therapy’s safety in non-human primates and...

Scientists Create Early Human Embryos From Skin Cells And Sperm

by admin | Oct 23, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By StudyFinds Analysis – Researchers have created human embryos by taking nuclei from ordinary skin cells, placing them into donated eggs, and fertilizing them with sperm. The work is a laboratory demonstration that shows what might eventually be possible for...

This “chaos enzyme” may hold the key to stopping cancer spread

by admin | Oct 22, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Science Daily – A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing key genes, EZH2 drives chaotic cell divisions and fuels metastasis. Blocking EZH2 restored stability and prevented...

New Tool Identifies Proteins That Control Gene Activity

by admin | Oct 21, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Weill Cornell Medicine – he SCOPE system can capture proteins binding to regions of DNA that control gene expression. The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the desired region....

Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality

by admin | Oct 20, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Tristan Manalac – BioSpace – Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move. Takeda will no longer invest in cell therapies moving...

New CAR T therapy targets solid tumours safely and effectively

by admin | Oct 17, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Drug Target Review – USC researchers have engineered CAR T cells to deliver a dual protein therapy that targets solid tumours – offering hope for cancers previously resistant to treatment. Chimeric antigen receptor (CAR) T-cell therapy, which uses a patient’s...